🔢 Codes · Family 04 of 14
Registry codes: END-THY · converted from the registry dossier families/04-thyroid.md — the dossier remains the source of truth; this page is its reading surface.
6 cards · 🟢 4 verified · 🟡 0 qualified · 🔴 2 disputed · ⚪ 0 qualitative — global registry: 41 disputed cards carry their dispute on the card.
Evidence-based numbers · Continuously updated · Fully referenced · Real live links
6 of 6 cards, in registry-code order
END-THY-CALC-01 · Transient hypocalcaemia
~20–30% · 10–20%
Biochemical ; symptomatic/clinical
Published split by definition — never merged (see Disputed Figures Table B)
🔴 Disputed · Registry audit 2026-11-06 · Pending triple review
Flip the card — population, dispute & sources
END-THY-CALC-02 · Permanent hypocalcaemia
1–3% · Definition context (added 2026-11-06, external-build audit): · Owner decision 2026-11-06: patient figure remains 1–3%
(corrected from <2%; Rosato 2.2% after total; Edafe median 1%, IQR 0–3%). Swedish nationwide register data using a continued-dispensing endpoint report 12.5% still on calcium/active vitamin D >1 year after total thyroidectomy, with 8.7% chart-validated permanent hypoparathyroidism (Annebäck et al., Ann Surg 2021, PMID 32032086; Br J Surg 2024 validation) — a different, broader endpoint than the validated-permanent-hypocalcaemia definition counselled here. ; the register figures are recorded for transparency and any future re-adjudication
Permanent hypocalcaemia requiring ongoing management
🟢 Verified · Registry audit 2026-11-06 · Pending triple review
Flip the card — population, dispute & sources
END-THY-COMP-01 · Postoperative haemorrhage
<2%
(source value 1.2%)
Bleeding requiring attention/intervention as reported in source series
🟢 Verified · Registry audit 2026-11-06 · Pending triple review
Flip the card — population, dispute & sources
END-THY-COMP-02 · Wound infection
<1%
(source value 0.3%)
Wound infection as reported in source series
🟢 Verified · Registry audit 2026-11-06 · Pending triple review
Flip the card — population, dispute & sources
END-THY-COMP-03 · Temporary voice weakness / transient RLN palsy
2–5%
(Rosato transient RLN palsy 2.0%; clinical average ~2.8% in Jeannon)
By clinical voice assessment (method qualifier mandatory — see Disputed Figures Table A)
🔴 Disputed · Registry audit 2026-11-06 · Pending triple review
Flip the card — population, dispute & sources
END-THY-COMP-04 · Permanent RLN palsy
1–2% · per patient · per nerve at risk
(Rosato 1.0% ; Jeannon 2.3% — denominators differ and are named here per the adjudication of 2026-11-06; the patient-facing 1–2% is the counselling range spanning both)
Permanent recurrent laryngeal nerve palsy
🟢 Verified · Registry audit 2026-11-06 · Pending triple review
Flip the card — population, dispute & sources